We outline the market outlook for diabetes DTx in the pharma and clinical research industry — from investment trends, to leading companies, to recommendations for players in the space.
What is digital therapeutics for diabetes?
Digital therapeutics (DTx) for diabetes includes apps and software that leverage evidence-based behavior change strategies, such as cognitive behavioral therapy (CBT), connected glucose monitors, and smart scales, to help patients manage and improve their diet and lifestyle choices.
Diet and lifestyle are the primary drivers of diabetes diagnosis and progression. Combining medication with therapy to modify behaviors can further improve the progression of diabetes treatment.
<![endif]-->
<script charset="utf-8" type="text/javascript" src=https://www.cbinsights.com/research/market-trend-report-digital-therapeutics-diabetes-solutions-pharma-cro-leaders/"//js.hsforms.net/forms/v2.js">
<script>
hbspt.forms.create({
onFormReady: function ($form) {
window.ClearbitForHubspot.addForm($form);
},
region: "na1",
portalId: "763793",
formId: "90955808-0135-4f5d-b9bc-c9c16290b2f4"
});
</script></div></div></div>"}" data-sheets-userformat="{"2":6657,"3":{"1":0},"12":0,"14":{"1":2,"2":4473924},"15":"Arial"}">FREE DOWNLOAD: THE COMPLETE DIGITAL HEALTH 150 LIST
Features & capabilities
Diabetes DTx apps and software provide pharma and clinical research organization (CRO) leaders with several capabilities, including:
- App-based digital CBT
- Personalized treatment plans
- Easy self-monitoring through condition-specific connected devices
- On-demand telehealth, including behavioral coaching and remote biomarker monitoring
- Multi-language format and interactive wellness apps
Want the full expert post? Become a CB Insights customer.
If you’re already a customer, log in here.
